News | October 23, 2013

St. Luke’s Medical Center Offers Molecular Breast Imaging

Technology provides accurate identification of tumors in women with dense breasts, implants

mammography systems nuclear imaging st. luke's discovery nm 750b GE healthcare
October 23, 2013 — St. Luke’s Medical Center is the first hospital in the Texas Medical Center to offer a molecular breast imaging (MBI) device that is sensitive enough to detect tiny tumors.  GE Healthcare’s Discovery NM 750b is designed to help improve detection of breast cancer, even in women with dense breasts where results of mammography may be inconclusive.
“The Discovery system is an important advancement in the early detection and diagnosis of breast cancer, but for women with dense breasts, it could truly be a lifesaver,” said Eric Ladwig, operations manager, nuclear medicine, St. Luke’s Medical Center. “Women with dense breasts have an increased risk of breast cancer and this condition can impact the quality of a traditional mammogram. MBI is not affected by breast density, resulting in a clear image and great confidence that the patient is cancer free or truly needs to have a biopsy.”
MBI is a comfortable examination, as only light immobilization pressure is required during studies versus a traditional mammography.
During an MBI procedure with Discovery, a patient receives a tracer injection that locates metabolically active tumors by blood flow. Because the tumor metabolizes the isotope to a higher degree than normal tissue, it will appear as a “hot spot” on the scan.
For more information:

Related Content

FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...
Novarad Debuts NovaMG-Pro Mammography Software at RSNA 2018
News | Mammography Reporting Software | November 25, 2018
Novarad Corp. announced new mammography software NovaMG-Pro, specifically for multimodality radiologists that read...
Volpara Solutions Showcases Latest VolparaEnterprise Software Tools at RSNA
News | Mammography | November 21, 2018
Volpara Solutions Inc. will showcase its latest artificial intelligence (AI) updates at the 104th Annual Radiological...